MicroRNA-145 regulates platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration by targeting CD40

American Journal of Translational Research

Volumn 8, Issue 4, 2016, Pages 1813-1825

  Li, Yumei ^a   Huang, Jiangnan ^b   Jiang, Zhiyuan ^b   Zhong, Yuanli ^b   Xia, Mingjie ^b   Wang, Hui ^c   Jiao, Yang ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

CD40; MicroRNA 145; Migration; Platelet derived growth factor; Proliferation; Vascular smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; CD40 ANTIGEN; EPIREGULIN; MESSENGER RNA; MICRORNA 145; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN; TRANSCRIPTION FACTOR AP 1;

AORTA; ARTICLE; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; METHYL THIAZOLYL TETRAZOLIUM ASSAY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; WOUND HEALING;

EID: 84966312287     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Hata A. Functions of microRNAs in cardiovascular biology and disease. Annu Rev Physiol 2013; 75: 69-93.
3. He L and Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
4. Rangrez AY, Massy ZA, Metzinger-Le Meuth V and Metzinger L. miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ Cardiovasc Genet 2011; 4: 197-205.
5. Quiat D and Olson EN. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest 2013; 123: 11-18.
6. Albinsson S and Sward K. Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease. Pharmacol Res 2013; 75: 28-36.
7. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES and Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105: 158-166.
8. Takahashi M, Hayashi K, Yoshida K, Ohkawa Y, Komurasaki T, Kitabatake A, Ogawa A, Nishida W, Yano M, Monden M and Sobue K. Epiregulin as a major autocrine/paracrine factor released from ERK-and p38MAPK-activated vascular smooth muscle cells. Circulation 2003; 108: 2524-2529.
9. Liu J, Ren Y, Kang L and Zhang L. Oxidized lowdensity lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin. Int J Mol Med 2014; 33: 1341-1347.
10. Wang J, An FS, Zhang W, Gong L, Wei SJ, Qin WD, Wang XP, Zhao YX, Zhang Y, Zhang C and Zhang MX. Inhibition of c-Jun N-terminal kinase attenuates low shear stress-induced atherogenesis in apolipoprotein E-deficient mice. Mol Med 2011; 17: 990-999.
11. Wahid F, Shehzad A, Khan T and Kim YY. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta 2010; 1803: 1231-1243.
12. Saiselet M, Gacquer D, Spinette A, Craciun L, Decaussin-Petrucci M, Andry G, Detours V and Maenhaut C. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer. BMC Genomics 2015; 16: 828.
13. Milenkovic D. MicroRNAs as novel nutrigenomic targets for cardiovascular health. Free Radic Biol Med 2014; 75 Suppl 1: S11.
14. Al-Kafaji G, Al-Mahroos G, Alsayed NA, Hasan ZA, Nawaz S and Bakhiet M. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes. Mol Med Rep 2015; 12: 7485-7490.
15. Gupta S, Verma S, Mantri S, Berman NE and Sandhir R. Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders. Drug Dev Res 2015; 76: 397-418.
16. Lagna G, Ku MM, Nguyen PH, Neuman NA, Davis BN and Hata A. Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors. J Biol Chem 2007; 282: 37244-37255.
17. Putta S, Lanting L, Sun G, Lawson G, Kato M and Natarajan R. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J Am Soc Nephrol 2012; 23: 458-469.
18. Millette E, Rauch BH, Kenagy RD, Daum G and Clowes AW. Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med 2006; 16: 25-28.
19. Riches K, Alshanwani AR, Warburton P, O’Regan DJ, Ball SG, Wood IC, Turner NA and Porter KE. Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function. J Mol Cell Cardiol 2014; 74: 240-250.
20. Quintavalle M, Elia L, Condorelli G and Courtneidge SA. MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol 2010; 189: 13-22.
21. Kim S and Kang H. miR-15b induced by platelet-derived growth factor signaling is required for vascular smooth muscle cell proliferation. BMB Rep 2013; 46: 550-554.
22. Li P, Liu Y, Yi B, Wang G, You X, Zhao X, Summer R, Qin Y and Sun J. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res 2013; 99: 185-193.
23. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L and Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009; 119: 2634-2647.
24. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN and Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460: 705-710.
25. Hu B, Song JT, Qu HY, Bi CL, Huang XZ, Liu XX and Zhang M. Mechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotype. PLoS One 2014; 9: e96338.
26. Turczynska KM, Sadegh MK, Hellstrand P, Sward K and Albinsson S. MicroRNAs are essential for stretch-induced vascular smooth muscle contractile differentiation via microRNA (miR)-145-dependent expression of L-type calcium channels. J Biol Chem 2012; 287: 19199-19206.
27. Song Z, Jin R, Yu S, Nanda A, Granger DN and Li G. Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventions. Arterioscler Thromb Vasc Biol 2012; 32: 50-64.
28. Yao Q, Xu H, Zhang QQ, Zhou H and Qu LH. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun 2009; 388: 539-542.
29. Ou H, Shen YH, Utama B, Wang J, Wang X, Coselli J and Wang XL. Effect of nuclear actin on endothelial nitric oxide synthase expression. Arterioscler Thromb Vasc Biol 2005; 25: 2509-2514.
30. Kang H and Hata A. MicroRNA regulation of smooth muscle gene expression and phenotype. Curr Opin Hematol 2012; 19: 224-231.
31. Mizuguchi Y, Takizawa T, Yoshida H and Uchida E. Dysregulated microRNAs in progression of hepatocellular carcinoma: A systematic review. Hepatol Res 2015; [Epub ahead of print].
32. Choi YC, Yoon S, Byun Y, Lee G, Kee H, Jeong Y, Yoon J and Baek K. MicroRNA library screening identifies growth-suppressive microRNAs that regulate genes involved in cell cycle progression and apoptosis. Exp Cell Res 2015; 339: 320-332.
33. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R and Olson EN. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 2009; 23: 2166-2178.
34. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA and Condorelli G. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009; 16: 1590-1598.
35. Hobert O. Gene regulation by transcription factors and microRNAs. Science 2008; 319: 1785-1786.
36. Makeyev EV and Maniatis T. Multilevel regulation of gene expression by microRNAs. Science 2008; 319: 1789-1790.
37. Zhang J, Zhao F, Yu X, Lu X and Zheng G. MicroRNA-155 modulates the proliferation of vascular smooth muscle cells by targeting endothelial nitric oxide synthase. Int J Mol Med 2015; 35: 1708-1714.
38. Li Y, Yan L, Zhang W, Hu N, Chen W, Wang H, Kang M and Ou H. MicroRNA-21 inhibits platelet-derived growth factor-induced human aortic vascular smooth muscle cell proliferation and migration through targeting activator protein-1. Am J Transl Res 2014; 6: 507-516.